The present study demonstrates that physical interactions between ARID2 and the transcriptional factor E2F1 play pivotal roles in ARID2-mediated suppression of cyclin D1 and cyclin E1, supporting the notion that ARID2 acts as a tumor suppressor by targeting the Rb-E2F signaling pathway. Here, E2F1 is linked to neoplasm.